<DOC>
	<DOCNO>NCT02387723</DOCNO>
	<brief_summary>The present aim perform small clinical safety trial heart failure patient allogeneic adipose tissue derive mesenchymal stem cell .</brief_summary>
	<brief_title>CSCC_ASC Therapy Patients With Severe Heart Failure</brief_title>
	<detailed_description>Patients heart failure treat culture expand adipose tissue derive mesenchymal stem cell healthy donor store nitrogen use . The cell inject directly myocardium use NOGA XP method . The patient follow 6 month safety efficacy registration .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>1 . 30 80 year age 2 . Signed informed consent 3 . Chronic stable IHD 4 . HF ( NYHA IIIII ) 5 . LVEF â‰¤45 % 6 . Maximal tolerable angina heart failure medication 7 . Medication unchanged two month prior inclusion 8 . Angiography within six month inclusion 9 . No option percutaneous coronary intervention ( PCI ) coronary artery bypass graft ( CABG ) 10 . Patients PCI CABG within six month inclusion must new angiography le one month inclusion least four month intervention rule early restenosis 11 . Patients include six month implantation cardiac resynchronisation therapy device 1 . Heart Failure ( NYHA I IV ) 2 . Acute coronary syndrome elevation CKMB troponins , stroke transitory cerebral ischemia within six week inclusion 3 . Other revascularisation treatment within four month treatment 4 . Moderate severe valvular disease valvular disease option valvular surgery 5 . Diminished functional capacity reason : coronary obstructive pulmonary disease ( COPD ) force expiratory volume ( FEV ) &lt; 1 L/min , moderate severe claudication morbid obesity 6 . Clinical significant anaemia , leukopenia , leukocytosis thrombocytopenia 7 . Clinically significant abnormal prothrombin partial thromboplastin time anticoagulation treatment pause cell injection 8 . Patients reduce immune response treat immunosuppressive medication 9 . History malignant disease within five year inclusion suspect malignity except treated skin cancer melanoma 10 . Pregnant woman 11 . Other experimental treatment within four week baseline test 12 . Participation another intervention trial</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>